ArticleFrontiers in oncology2025
Differentiating pancreatic ductal adenocarcinoma and autoimmune pancreatitis using a machine learning model based on ultrasound clinical features.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Image-based artificial intelligence for preoperative differentiation of pancreatic cancer from pancreatitis: a systematic review and meta-analysis.Frontiers in oncology · 2025Pooled it
- Development and validation of machine learning models integrating spectral computed tomography-derived three-dimensional quantitative parameters for predicting histopathological grade in pancreatic ductal adenocarcinoma.Journal of gastrointestinal oncology · 2026Article
- Artificial intelligence in chronic and autoimmune pancreatitis: diagnosis, prognosis, and personalized management.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to construct a differential diagnostic model to distinguish autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDCA) using ultrasound clinical features and machine learning algorithms. Methods: Retrospective ultrasound clinical data of patients with AIP and PDCA from three different centers were used as the training cohort, external validation cohort 1, and external validation cohort 2. Feature selection was conducted via variance filtering and LASSO regression, followed by the construction of a random forest (RF) model. The hyperparameters were optimized in the training cohort, and the final model was evaluated in the external validation cohorts. The model's performance was assessed using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), the F1 score, accuracy, and area under curve(AUC). The clinical application value of the model was clarified through a comparison between humans and machines. Results: An RF model was constructed using six features: Ca 19-9 level, abdominal pain, jaundice, focal/diffuse-type AIP, blood flow signals, and morphology. In external validation cohort 1, the model's sensitivity, specificity, PPV, NPV, F1 score, accuracy, and AUC were 86.0%, 80.0%, 81.0%, 86.0%, 84.0%, 83.0%, and 89.0%, respectively; in external validation cohort 2, these values were 72.0%, 94.0%, 93.0%, 77.0%, 81.0%, 83.0%, and 91.0%, respectively. The predictive performance of experienced radiologists using clinical information and ultrasound images demonstrated a sensitivity of 81%, specificity of 79%, PPV of 78%, NPV of 76%, F1 score of 80%, and accuracy of 80%. For radiologists with intermediate experience, the sensitivity was 75%, specificity was 74%, PPV was 73%, NPV was 76%, F1 score was 74%, and accuracy was 75%. less experienced radiologist had a sensitivity of 55%, specificity of 56%, PPV of 62%, NPV of 49%, F1 score of 58%, and accuracy of 55%. Conclusion: The RF model constructed using clinical ultrasound features achieved diagnostic levels comparable to those of experienced radiologists and can assist in differentiating AIP from PDCA, potentially guiding clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.